DAPA-HF

The DAPA-HF trial assessed the efficacy and safety of dapagliflozin in patients with heart failure and a reduced ejection fraction, with or without diabetes. This module details the results.

DAPA-HF
Rate this content
  • DAPA-HF
  • DAPA-HF
  • DAPA-HF
  • DAPA-HF: trial design1,2
  • DAPA-HF: key inclusion and exclusion criteria1,2
Do you want to go to the Presentation Builder section to create a new presentation?
Cancel Go